Founded in 2018 and headquartered in the United States, Prenuvo received a significant $70.00M Series A investment on 18 October 2022. The round was backed by prominent investors including Felicis Ventures, Steel Perlot, Anne Wojcicki, Cindy Crawford, Rande Gerber, Timothy A. Springer, and Tony Fadell. Prenuvo's innovative approach to proactive health screening aligns with the growing demand for comprehensive and personalized healthcare, positioning it as a notable player in the healthcare industry.
Prenuvo
Saving lives with breakthrough proactive cancer & major disease screening
Founded 2018
Redwood City, United States
329 employees
Series A
Total: $70.00M
Health Care
Redwood City, United States
329 employees
Series A
Total: $70.00M
Health Care
General Information
Company Name
Prenuvo
Founded Year
2018
Location
Redwood City, United States
Redwood City, United States
Employees
329
Industries
Health Care
Funding Stage
Series A
BounceWatch is an independent company data service, not affiliated with Prenuvo. To contact Prenuvo, visit prenuvo.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Prenuvo compare?
A PDF of Prenuvo and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Prenuvo soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Health Care
About Prenuvo
Business keywords: health tech, diagnostic imaging, cancer screening, disease screening, whole body MRI, early detection, AI-augmented analysis, comprehensive scans, health decisions, global healthcare, proactive screening, radiology, patient empowerment
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | Undisclosed | - |
|
18 Oct 2022 |
| Series A | $70.00M | 7 |
|
18 Oct 2022 |
| Series A | Undisclosed | 1 |
|
01 Jan 2021 |
Latest News
View All
Prenuvo Alternatives & Competitors
View All Alternatives
Prenuvo vs
Ezra
United States
Detecting cancer early using Full Body MRIs
Series B
81 employees
AI, Health Care
Prenuvo vs
Prenuvo vs
Rhode Island Medical Imaging
United States
World class medical imaging, focusing on you.
238 employees
Health Care
FAQ About Prenuvo
Saving lives with breakthrough proactive cancer & major disease screening
Prenuvo was founded in 2018.
Prenuvo is headquartered in Redwood City, United States.
Prenuvo operates in Health Care. Its work centres on health tech, diagnostic imaging, cancer screening and disease screening.
Prenuvo has approximately 329 employees.
Prenuvo has completed 3 funding rounds, raising a total of $70.00M. The latest funding stage is Series A.
Top alternatives and competitors to Prenuvo include Ezra, The Radiology Clinic, Rhode Island Medical Imaging, Hexarad, Delphinus Medical Technologies, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Prenuvo and Ezra are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Prenuvo, https://bouncewatch.com/company/prenuvo, updated 30 December 2024. When citing, please name BounceWatch and link this page.
